NCT07205718 2026-02-06
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
Takeda
Phase 1/2 Recruiting
Clinical Trials
8 trialsNCT04381650 2025-12-10
A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors
Takeda
Phase 1/2 Completed
NCT01928394 2024-12-27
A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Completed
NCT03316638 2024-12-10
Ulysse
Pierre Fabre Medicament
Phase 1/2 Terminated
NCT05399654 2024-08-16
INCLINE-101
Tallac Therapeutics
Phase 1/2 Active not recruiting
NCT05693844 2024-05-10
Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors
Chinese PLA General Hospital
Phase 1/2 Recruiting
NCT05652855 2023-01-09
Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors
Minghui Pharmaceutical Pty Ltd
Phase 1/2 Not yet recruiting
NCT04843709 2022-09-08
A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors
Shanghai Miracogen Inc.
Phase 1/2 Unknown